About Neovacs
Neovacs, a biotech company, develops several therapeutic vaccines for the treatment of AIDS, cancer and auto-immune and allergic diseases.
Leadership & Decision Makers
Contact details of 4 Neovacs decision makers
Miguel Sieler
Chief Executive Officer
No contact data available
Vincent Serra
Chief Scientific Officer
No contact data available
Daniel Zagury
Founder
No contact data available
Charlène Masson
Corporate Communication Director
No contact data available
General Emails
General company emails, e.g. customer support lines
contact@neovacs.com
General Inquiries
info@neovacs.fr
General Inquiries
bernardfanget@neovacs.fr
Unclassified inbox
geraldinevogel@neovacs.fr
Unclassified inbox
Similar Companies like Neovacs
Biotechnology · Lebanon, New Hampshire, United States · Est. 2007 · 101–250 employees
HQ: Lebanon, New Hampshire, United States
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B
HQ: Bothell, Washington, United States
Company Info
Updated 31/07/2025
Specialization
Therapeutics,
Business Type
Public
Employees
11-50
Rounds
Post-IPO Debt
Founded Date
1993
Number of Exits
1
Company Type
For Profit
Stock Symbol
EPA:ALNEV
Operating Status
Active
Last Funding Type
Post-IPO Debt
Phone Number
33 1 53 10 93 00
Last Investment Activity
Jun 17, 2024
Investments Activity
Jun 17, 2024May 27, 2024Jan 17, 2024
Frequently Asked Questions about Neovacs
What does Neovacs do?
Neovacs, a biotech company, develops several therapeutic vaccines for the treatment of AIDS, cancer and auto-immune and allergic diseases.
Where is Neovacs headquartered?
Neovacs is headquartered in Paris, Ile-de-France, France.
When was Neovacs founded?
Neovacs was founded in 1993.
How many employees does Neovacs have?
Neovacs has approximately 11-50 employees.
What industry is Neovacs in?
Neovacs operates in the Biotechnology industry.
How do I contact Neovacs?
You can contact Neovacs via email at contact@neovacs.com or info@neovacs.fr, headquartered in Paris, Ile-de-France, France.
